| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/14/2004 | US6792132 Inspection method for microorganisms and the like, and unit therefor |
| 09/14/2004 | US6791011 For producing male-sterile plants and hybrid seeds; cell ablation |
| 09/14/2004 | US6791007 Polynucleotide and its use for modulating a defence response in plants |
| 09/14/2004 | US6790965 Inhibition of carbonic anhydrase isozymes; glaucoma |
| 09/14/2004 | US6790952 Using polymerase chain reaction to detect/diagnose viral infections; viricides |
| 09/14/2004 | US6790950 Anti-bacterial vaccine compositions |
| 09/14/2004 | US6790949 Used in the development of a therapeutic agent for neuron or endocrine cell-related diseases; vesicle transport proteins |
| 09/14/2004 | US6790946 Synthesis of oligonucleotides |
| 09/14/2004 | US6790945 Fluorescent quenching detection reagents and methods |
| 09/14/2004 | US6790941 Zinc finger protein derivatives and methods therefor |
| 09/14/2004 | US6790826 Human haemopoietic maturation factor |
| 09/14/2004 | US6790656 Galanin receptors (galr2); involved in various neurological and neurodegenerative disorders and treatments |
| 09/14/2004 | US6790651 Hybridization reaction apparatus and hybridization method |
| 09/14/2004 | US6790649 Phex gene (phosphate regulating gene with homologies to endopeptidases on x chromosome); for treatment of x-linked hypophosphatemia (xlh), a phosphate homeostasis disorder; retardation, bone, renal and metabolism disorders |
| 09/14/2004 | US6790645 Oxidation of a cyclohexanone derivative using a brevibacterium cyclohexanone monooxygenase |
| 09/14/2004 | US6790642 Method for reducing the amount of nucleic acid adhering to a hydrophobic surface |
| 09/14/2004 | US6790639 Bone morphogenic proteins; for regulating bone homeostasis, adiposity, and calcification of atherosclerotic plaques |
| 09/14/2004 | US6790638 Method for selecting tumours expressing HLA-G, sensitive to anticancer treatment and uses |
| 09/14/2004 | US6790635 By measuring human lipocalin-type prostaglandin d synthase (l-pgds) in a body fluid sample |
| 09/14/2004 | US6790633 Prevents binding of ras protein in malignant cells |
| 09/14/2004 | US6790629 Receptor polypeptide for use in the treatment and diagnosis of painful syndromes |
| 09/14/2004 | US6790628 Screening granulocyte colony stimulating factor(g-csf) poly-peptide analogs to use as g-csf replacements or antagonists; sensitizing cells to chemo/radiotherapy; treating hemato-poietic, neurological or reproduction related conditions |
| 09/14/2004 | US6790626 Comprises preference for pyrimidine nucleotides (uridine triphosphate) over purine nucleotides; for determining ligand binding, detecting expression, drug screening, treatment |
| 09/14/2004 | US6790623 DNA detection by means of a strand reassociation complex |
| 09/14/2004 | US6790622 Tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof |
| 09/14/2004 | US6790621 Method of detecting ivermectin sensitivity in a canine subject by identifying a mutation in a mdr1-encoding sequence |
| 09/14/2004 | US6790620 Small volume chambers |
| 09/14/2004 | US6790619 Plant phosphomevalonate kinases |
| 09/14/2004 | US6790618 By detecting the presence or absence of the -3 t allele in position -3 of exon 6 of sur1 (sulfonylurea receptor 1) gene; non-insulin dependent diabetes (niddm) |
| 09/14/2004 | US6790616 Useful for judgement of compatibility between donor and recipient in organ transplantation, and for association analysis between the hla (human leukocyte antigen) class i genes and various types of diseases |
| 09/14/2004 | US6790612 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease |
| 09/14/2004 | US6790610 Alzheimer's disease, secretase, APP substrates therefor, and uses therefor |
| 09/14/2004 | US6790607 Comprises overexpression of bait hybrid protein containing a dna binding domain (desensitization) or prey hybrid protein containing a dna activation domain for a reporter gene (enhanced sensitivity); uses exogenous activators |
| 09/14/2004 | US6790605 Methods for obtaining a desired bioactivity or biomolecule using DNA libraries from an environmental source |
| 09/14/2004 | US6790604 Methods for identifying or diagnosing carcinoma cells with metastatic potential based on the measurement of lymphoid genes or their products in carcinoma cells |
| 09/14/2004 | US6790330 For detecting marker proteins and mrnas for diagnosis of cancer |
| 09/14/2004 | US6790327 Device and method for determining the concentration of a substrate |
| 09/14/2004 | CA2200605C Compositions and methods for the detection of chlamydia trachomatis |
| 09/14/2004 | CA2071924C Hepatocellular carcinoma oncogene |
| 09/12/2004 | CA2456534A1 Simultaneous determination of cell proliferation inhibition activity and toxicity |
| 09/10/2004 | WO2004077058A1 Diagnostics and therapeutics for diseases associated with aryl hydrocarbon receptor (ahr) |
| 09/10/2004 | WO2004077057A1 Standard for immunohistochemistry, immunocytochemistry and molecular cytogenetics |
| 09/10/2004 | WO2004077055A1 Method of detecting onset risk of encephalitis or encephalopathy |
| 09/10/2004 | WO2004077054A1 Quality control of binding measurements on microarrays |
| 09/10/2004 | WO2004077053A1 Cathepsin y for the treatment of pain |
| 09/10/2004 | WO2004077041A1 Analytic chip for quantifying nucleic acid concentration, analytic device for quantifying nucleic acid concentration and analytic method for quantifying nucleic acid concentration |
| 09/10/2004 | WO2004077017A2 Apparatus and method for on-chip concentration using a microfluidic device with an integrated ultrafiltration membrane structure |
| 09/10/2004 | WO2004077014A2 Methods and compositions for detection and analysis of polynucleotide-binding protein interactions using light harvesting multichromophores |
| 09/10/2004 | WO2004076694A1 Method of detecting chlamydia trachomatis and kit therefor |
| 09/10/2004 | WO2004076693A1 Tailored treatment suitable for different forms of mastocytosis |
| 09/10/2004 | WO2004076692A1 Dna sequence analysis |
| 09/10/2004 | WO2004076691A1 Amp assay |
| 09/10/2004 | WO2004076690A2 Use of a mutation in the human gnas gene for predicting risks of disease, courses of diseases, and for predicting the response to treatments of disease |
| 09/10/2004 | WO2004076689A1 Method of screening compounds which inhibit the initiation of the retrotranscription of the rna of virus hiv-1 and means for implementing same |
| 09/10/2004 | WO2004076688A1 Method of monitoring asymptomatic nephropathy |
| 09/10/2004 | WO2004076687A1 Method for determining antiviral activity of ahps related compounds |
| 09/10/2004 | WO2004076686A1 Method of examining cell |
| 09/10/2004 | WO2004076685A2 Fungal biosensor and assay |
| 09/10/2004 | WO2004076684A2 Compositions and methods for the detection of mammalian muscle troponin i |
| 09/10/2004 | WO2004076683A2 Random array dna analysis by hybridization |
| 09/10/2004 | WO2004076682A2 Targets for controlling cellular growth and for diagnostic methods |
| 09/10/2004 | WO2004076679A2 Serum macrophage migration inhibitory factor (mif) as marker for prostate cancer |
| 09/10/2004 | WO2004076675A2 Glutamate transport modulatory compounds and methods |
| 09/10/2004 | WO2004076657A2 Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides |
| 09/10/2004 | WO2004076649A2 Methods, systems and apparatus for identifying genetic differences in disease and drug response |
| 09/10/2004 | WO2004076643A2 CIRCULATING TUMOR CELLS (CTC’s): EARLY ASSESSMENT OF TIME TO PROGRESSION SURVIVAL AND RESPONSE TO THERAPY IN METASTATIC CANCER PATIENTS |
| 09/10/2004 | WO2004076641A2 New microorganism implicated in intestinal diseases, alzheimer’s disease and other diseases |
| 09/10/2004 | WO2004076639A2 Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus |
| 09/10/2004 | WO2004076636A2 A novel human g-protein coupled receptor, hgprbmy23, expressed highly in kidney |
| 09/10/2004 | WO2004076632A2 Methods of screening for trpm5 modulators |
| 09/10/2004 | WO2004076629A2 METHODS AND CONSTRUCTS FOR EVALUATION OF RNAi TARGETS AND EFFECTOR MOLECULES |
| 09/10/2004 | WO2004076628A2 Overexpression, purification and characterization of a thermolabile phosphatase |
| 09/10/2004 | WO2004076621A2 Compositions of nucleic acids for treating and detecting influenza virus |
| 09/10/2004 | WO2004076619A2 New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
| 09/10/2004 | WO2004076613A2 Human nucleic acid sequences from carcinomas of the bladder |
| 09/10/2004 | WO2004076054A2 Dry chemistry, lateral flow-reconstituted chromatographic enzyme-driven assays |
| 09/10/2004 | WO2004075932A1 Sterilization indicator test packs |
| 09/10/2004 | WO2004075861A2 Recombinant adeno-associated virus production |
| 09/10/2004 | WO2004075839A2 Methods and compositions for modulating apoptosis |
| 09/10/2004 | WO2004075835A2 Methods for the treatment of renal cell carcinoma |
| 09/10/2004 | WO2004075833A2 Methods of determining a chemotherapeutic regimen based on loss of heterozygosity at the thymidylate synthase locus |
| 09/10/2004 | WO2004075831A2 Pharmacodynamic assay for inhibitors of 11-beta-hydroxysteroid dehydrogenase activity in animal tissues |
| 09/10/2004 | WO2004075813A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep3 ii (prostaglandin e2 ep3 ii) |
| 09/10/2004 | WO2004075812A2 Diagnostics and therapeutics for diseases associated with phosphodiesterase 3b (pde3b) |
| 09/10/2004 | WO2004075733A2 Construction of a deafness gene chip |
| 09/10/2004 | WO2004075723A2 Methods for the early diagnosis of ovarian cancer |
| 09/10/2004 | WO2004065626A3 A method of sepsis prognosis |
| 09/10/2004 | WO2004062338A3 Method for determining the amount of template nucleic acid present in a sample |
| 09/10/2004 | WO2004060135A3 Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients |
| 09/10/2004 | WO2004058175A3 Novel use of liver x receptor agonists |
| 09/10/2004 | WO2004051218A8 Multiplex amplification of polynucleotides |
| 09/10/2004 | WO2004051214A3 Use of fluorine nmr for high throughput screening |
| 09/10/2004 | WO2004045548A3 Genetic constructs and compositions comprising rre and cte and uses thereof |
| 09/10/2004 | WO2004044148A3 Methods for the identification of trehalose-6-phosphate synthase as antibiotics |
| 09/10/2004 | WO2004044131A8 Cross-linked oligomeric compounds and their use in gene modulation |
| 09/10/2004 | WO2004042075A3 Inactivated ga1 - nac - transferases, methods for inhibitors of such transferases and their use |
| 09/10/2004 | WO2004034994A3 Methods and compositions for determining risk of treatment toxicity |
| 09/10/2004 | WO2004033622A3 Preservation of rna and morphology in cells and tissues |
| 09/10/2004 | WO2004031728A3 Method and system for producing customized skin care formulations using genetic information |
| 09/10/2004 | WO2004031397A3 Detection of evolutionary bottlenecking by dna sequencing as a method to discover genes of value |